ASH 2023

Area: Oncology

Location: San Diego, United States

Date: December 9 to December 12


Search in Scientific Content:
Date
Filters:
Follicular
12:06

Follicular Lymphoma highlights of the ASH 2023 Congress

Presenter: Carla Casulo
Oncology : Hematology
Highlights
9:22

Highlights of the ASH 2023 Congress

Presenter: Mikkael Sekeres
Oncology : Hematology
Present an
14:07

Present and future of Multiple Myeloma management

Presenter: Xavier Leleu
Oncology : Hematology
Ibrutinib-
5:010

Ibrutinib-Venetoclax Combination Found Effective Against Mantle Cell Lymphoma

Presenter: Michael Wang
Oncology : Hematology
Real-World
5:20

Real-World Outcomes With Brexucabtagene Autoleucel

Presenter: Swetha Kambhampati
Oncology : Hematology
Frontline
8:20

Frontline Treatment With Targeted Agents in Patients With Chronic Lymphocytic Leukemia - report from ASH2023

Presenter: Adrian Wiestner
Oncology : Hematology
Dramatical
6:21

Dramatically Worse Myeloma Outcomes in Real World vs. Trials

Presenter: Alissa Visram
Oncology : Hematology
Multiple M
10:58

Multiple Myeloma highlights of ASH 2023 Congress

Presenter: Andrzej Jakubowiak
Oncology : Hematology
Chronic My
12:36

Chronic Myeloid Leukemia highlights of ASH 2023 Congress

Presenter: Giuseppe Saglio
Oncology : Hematology
Acute myel
4:57

Acute myeloid leukemia highlights of ASH 2023 Congress

Presenter: Eunice S. Wang
Oncology : Hematology
Chronic My
5:50

Chronic Myeloid Leukemia: Novel Therapeutic Approaches

Presenter: Carmen Fava
Oncology : Hematology
Non-Hodgki
8:31

Non-Hodgkin Lymphoma highlights of the ASH 2023 Congress

Presenter: Umberto Vitolo
Oncology : Hematology
Diagnostic
11:52

Diagnostic and Therapeutic Novelties of Multiple Myeloma Management

Presenter: Enrique Ocio
Oncology : Hematology
Acute myel
4:45

Acute myeloid leukemia highlights of the ASH 2023 Congress

Presenter: Agnieszka Wierzbowska
Oncology : Hematology
State of t
9:14

State of the art ALL treatement in 2023

Presenter: Marlise R. Luskin
Oncology : Hematology
Revumenib
4:01

Revumenib Found Effective Against High-Risk KMT2Ar Acute Leukemia

Presenter: Ibrahim Aldoss
Oncology : Hematology

Bratislava 2014

2014-10-09 - 2014-10-10
Bratislava, Slovakia

ESMO 2014

2014-09-26 - 2014-09-30
Madrid, Spain